logo-loader
AIM:NCYT OTC:NVYTF EPA:ALNOV

Novacyt SA

Receive alerts
Market:
AIM
Price
44.06 GBX
Day Change
-0.43%
Market Cap:
£31.12 m
52 weeks high
86.00
52 weeks low
35.80

In brief

Novacyt SA is an international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. 

Its core strengths lie in diagnostics product development, commercialisation, contract design and manufacturing.

The company's lead business units comprise of Primerdesign and Lab21 Products, supplying an extensive range of high-quality assays and reagents worldwide.

Novacyt directly serves microbiology, haematology and serology markets as do its global partners, which include major corporates.